CompletedNCT03947827
Minocycline Added to Care for Treatment-Resistant Depression
About this title
Read the official source — NCT03947827This study assessed depression symptoms.
Medication studyAges 18–80Canada
Understand this study
What did researchers investigate?
This study assessed depression symptoms.
Who was this study for?
Listed age limits: 18 years to 80 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: February 1, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 76
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT03947827
- Official title
Show the full official title
Minocycline as Adjunctive Treatment for Treatment Resistant Depression: a Double Blind, Placebo-controlled, Randomized Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study assessed depression symptoms.
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Minocycline.
Who was this study for?
Listed age limits: 18 years to 80 years.
